Tissue Regenix Group plc (LON:TRX) is focused on the development and commercialisation of two proprietary processing technologies for the repair of soft tissue (dCELL) and bone (BioRinse). It has a
Palace Capital plc (LON:PCA) March 2021 annual results were ahead of our expectations; notably, rent was £17.3m vs. our estimated £16.4m. FY20 rent stood at £18.3m, excluding a lease surrender
CyanConnode Holdings plc (LON:CYAN) has announced a non-binding Memorandum of Understanding (MOU) with IntelliSmart, a partially state-owed entity that is at the centre of the smart meter rollout programme in
How these returns were delivered: Our September 2020 note Defensive growth: explaining downside resilience noted why PE outperforms in downturns. ICG Enterprise Trust plc (LON:ICGT) further reduces risk with a “defensive
Shield Therapeutics plc (LON:STX) is a commercial-stage pharmaceutical company delivering specialty products that address patients’ unmet medical needs, with an initial focus on treating iron deficiency (ID). Feraccru®/Accrufer® has been
Oakley Capital Investments Limited (LON:OCI) hosted its annual Capital Markets day on 18 May 2021. With presentations from Oakley Capital and investee companies, as well as Q&A, including the OCI
Cizzle Biotechnology Ltd (LON:CIZ) was identified by Bould Opportunities (Bould) as its preferred target for a reverse takeover. Cizzle is a spin-out from the University of York to exploit the
Fidelity Asian Values plc (LON:FAS) gives investors liquid access to the attractive small-cap Asian market (ex-Japan). Its long-term returns have beaten UK markets, Asian benchmarks, listed peers and open-ended fund
The key messages we take from Real Estate Credit Investments plc (LON:RECI) April’s quarterly investor update and end-March 2021 factsheet are i) mark-to-market (MTM) writedowns in March 2020 proved overly
In this note, we explore how favourable market conditions mean that CLO vehicles can re-finance debt cheaply, thus enhancing the value of Volta Finance Ltd (LON:VTA) equity positions, which have
© 2024 – DirectorsTalk. All rights reserved. Reproduction in whole or in part, in any form or medium without express written permission is prohibited.
